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Expression of the avp3 integrin is upregulated on sprouting 
endothelia. Systemic application of antibody or peptidic 
inhibitors of avp3 function disrupts tumor angiogenesis and 
reduces growth and invasiveness of human tumors in animal 
models. We systematically investigated avp3 expression on 
tumor-associated vessels of 4 different human epithelial tu­
mors and the corresponding normal tissues by means of 
immunohistochemistry on frozen sections using the cevp3~ 
complex specific monoclonal antibody LM609. Variable levels 
of LM609 staining were found in all carcinoma lesions. A 
considerable number of tumor tissues (35/50) expressed 
av(53 on more than 50% of their vessels. Inflammatory 
infiltrates and the possibly hypoxic conditions near necrotic 
areas of tumors were accompanied by an increased otvp3 
expression. Remarkably, the vasculature in apparently nor­
mal tissue also stained for avP3. However, the percentages of 
stained vessels and their staining intensity were lower than in 
neoplastic tissues. Besides the vascular ctvp3 expression, 
several extravascular ceil types stained positive, in both 
normal and tumor specimens. Taken together, our findings 
show a considerable number of coJon, pancreas, lung and 
breast carcinoma lesions with many ctvp3-expressing vessels 
that could be targets for antUavp3-therapy. Int. y. Cancer
71:320-324, 1997.
© 1997 Wiley-Liss, Inc.
A ngiogenesis, the form ation o f new blood vessels from pre­
existing ones, plays a key role in developm ent, wound repair and 
inflammation. This process also contributes to pathological condi­
tions such as diabetic retinopathy, rheum atoid arthritis and cancer. 
A fter solid tumors reach a volum e of 1 -2  m m 3, their further 
outgrowth is strictly dependent on angiogenesis (Folkman, 1992). 
In several human tum ors an association between vascular density—  
quantified by microvessel counting— and tumor metastasis or 
prognosis has been reported; studies included cutaneous melanoma 
(Srivastava e t a l ,  1988) and squamous-cell carcinomas of head and 
neck (Gasparini et a l , 1993), stomach (M aeda et al., 1995), lung 
(M acchiarini et a i ,  1992) and breast (Gasparini and H am s, 1995). 
Thus, there is m uch interest in developing therapeutic agents that 
inhibit tum or angiogenesis.
The form ation o f new blood vessels is characterized by invasion, 
m igration and proliferation of endothelial and smooth-muscle cells. 
Vascular adhesion m olecules contribute to these processes (Ingber, 
1991). Several m em bers of the integrin family of adhesion 
m olecules are expressed on the surface of cultured endothelial and 
sm ooth-m uscle cells (Cheresh, 1987). Among these heterodimeric 
m olecules the integrin fam ily m em ber av|33 is strongly implicated 
in the angiogenic response o f endothelial cells. Furthermore, avp3  
has been described as a m arker for sprouting angiogenic vessels 
and has been found in healing wounds, whereas no expression was 
detectable on vessels in norm al skin (Brooks e t a l , 1994a). In line 
with this, cytokines are able to induce av(33 expression on cultured 
m icrovascular endothelial cells (Swerlick et al., 1993).
R ecent findings in a severe combined immunodeficiency (SCID) 
m ouse/hum an skin chim eric m odel indicated that the intravenous 
application of a function-blocking monoclonal antibody (MAb) 
(LM 609) directed to the av  (33-complex is able to reduce the 
growth and invasiveness o f  human tumors. This seems to be due to 
the perturbation of angiogenesis induced by the tumors, with no
apparent effect on surrounding normal tissue (Brooks et a l,  1995). 
In a chorioallantoic m em brane (CAM) model, both peptidic and 
antibody antagonists of av(33 strongly blocked tumor-induced 
angiogenesis (Brooks et al., 1994a,b). These data suggest that 
integrin a v p 3  might be a useful therapeutic target for cancer and 
other diseases characterized by pathological angiogenesis.
Several studies have investigated the distribution of av- and 
(33-integrins on vessels (M echtersheim er et a l ,  1994; Luscinskas et 
al., 1994), but until now the use of a complex-specific antibody 
against the m ost interesting target, av p 3 , has been limited. As 
different a v - and (33-integrins are known, the reagents directed to 
individual chains m ust give ambiguous results.
Here, our interest was to investigate which solid human tumors 
show marked a v p 3  expression on their vascular beds and could 
thus possibly be targets for treatment with avP3-antagonists. We 
compared the otvp3 expression on the vasculature of human tumors 
with that in the corresponding normal tissues by means of 
im nuinohistochem ical analysis of serial frozen sections.
MATERIAL AND METHODSj
Clinical material
Frozen surgical m aterial and histologically norma) specimens 
from autopsy, performed within 4 hr post-mortem (Department of 
Pathology, U niversity H ospital Nijmegen) were used. The follow­
ing sam ples w ere investigated: colorectal adenocarcinomas 
(n =  15), pancreas carcinom as (n =  10), lung carcinomas (n =  13), 
breast carcinomas (n =  12) and normal colonic (n =  5), pancreatic 
(n =  5), lung (n =  3) and breast tissue (n =  3).
Immunohistochemical techniques
Sections of the frozen material were stained with the anti-avfS3 
monoclonal antibody LM 609 (a kind gift o f Dr. D. Cheresh, La 
Jolla, CA) and the anti-endothelial cell MAb PAL-E, a specific 
marker for small veins, venules and capillaries, which was used as 
a reference for endothelial staining (Schlingemann et al., 1985), 
Serial 4-pm  sections of frozen tissue were air-dried overnight at 
room  temperature (RT), fixed in acetone for 10 min, again air-dried 
and then incubated with PAL-E (undiluted hybridoma supernatant) 
and LM 609 (2.55 pg/ml) at RT for 60 min. Overnight drying did 
not result in artifactual or background staining with either antibody. 
After the sections had been rinsed in PBS, PAL-E was detected by 
incubation at RT with a alkaline phosphatase(AP)-conjugated 
rabbit anti-mouse antibody (RAM-AP, Dakopatts, Glostrup, Den­
mark). For LM609, in addition to RAM-AP, a third step with 
AP-conjugated swine anti-rabbit antibody (Dakopatts) was neces­
sary to enhance the specific staining signal. All MAbs were diluted 
in PBS (pH =  7.4) containing 1% BSA. As substrates, Naphtol 
AS-TR phosphate in TRIS-buffer, levamisole and Fast red TR were 
used.
^Correspondence to: Department of Pathology, University Hospital 
Nijmegen, P.O. Box 9101,6500 HB Nijmegen, The Netherlands. Fax: 31 24 
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F igure 1 -  Microphotographs of normal colonic tissue. Serial 
cryostat sections were stained with the endothelial marker PAL-E (a) 
and LM609 anti-avp3 MAb (b). Arrowheads indicate an arteriole, 
arrows indicate a venule. M, Lamina mucosa; S, tela sub mucosa; m, 
tunica muscularis. Bars; 66 \xm,
Finally, sections were counterstained with Mayer’s hematoxylin 
and mounted with Kaiser’s glycerol-gelatin (Merck, Darmstadt, 
Germany). This protocol was used for all lesions except the colonic 
tissues. As the endogenous alkaline phosphatase in colonic tissue 
causes non-specific background staining, second and third antibod­
ies were replaced. For PAL-E a peroxidase-conjugated rabbit 
anti-mouse antibody (RAMPO, Dakopatts) was used, for LM609 
the peroxidase-based Vectastain elite ABC kit (Vector, Burlingame, 
CA). This was followed by incubation with 0.5 mg/ml DAB (3,3' 
diaminobenzidine-tetrahydrochloride, Sigma (St, Louis, MO). Then 
the sections were treated for 5 min with a 0.9% NaCl solution 
containing 0.5% CuS04 and counterstained with Mayer’s hematoxy­
lin. Finally, the sections were dehydrated and mounted with 
Permount (Boom, Meppel, The Netherlands). Controls consisted of 
incubations replacing the primary antibodies with PBS/BSA, with 
other anti-integrin MAbs of the same isotype but with different 
specificity, and with an unrelated Mab of the IgGj isotype.
Vascular av[33 expression
Stained slides were scored independently for antigen expression 
by 2 investigators using light microscopy. On sections stained with 
the endothelial marker PAL-E, any red- (AP) or brown-staining 
(DAB) cell or cluster of cells was considered to be a single 
countable micro vessel independent of the presence of a lumen. 
Individual microvessel counts were made in at least 4 different 
fields per section (magnification X250) and compared with simiLar 
areas of serial sections stained for av|33. Each PAL-E-defined 
(micro-)vessel showing LM609 staining above the parallel second- 
layer controls was counted as positive. A magnification of X250 
was necessary to unequivocally distinguish staining of endothelial 
cells from that of media.
Results are expressed as mean percentage of av|33-expressing 
(micro-)vessels as a fraction of the PAL-E-defined (micro-)vessels.
RESULTS
Table I shows the mean number, standard deviation and range of 
evaluated PAL-E-positive structures per field in neoplastic and 
normal tissues, The percentages of av(33-expressing (micro-) 
vessels are summarized in Table II. To verify the specificity of the
TABLE I -  MEAN NUMBER OF EVALUATED PAL-E-DEFINED VESSELS PER 
FIELD (MAGNIFICATION X250) IN NEOPLASTIC AND NORMAL TISSUES
Number of evaluated vessels per fieldTissues - ----------------------------------------
Mean ± SD1 Range
Colon carcinoma 31.3 ±  13.2 14-66
n = 15
Normal colon 17.8 ± 1.3 16-20
n — 5 (submucosa)
Pancreas carcinoma 54.2 ±  24.2 12-89
n = 10
Normal pancreas 142.2 ± 8 .7 130-157IIr-j
Lung carcinoma 44,7 ±  25 7-95
n = 13
Normal lung 83 ± 31 54-126
n = 3
Breast carcinoma 46.8 ±  16.8 15-80
n = 12
Normal breast 9.3 ± 2.1 7-12
n = 3
*SD, standard deviation.
This study was not performed to compare vessel densities of normal 
and cancerous tissues and the numbers in this table should not be taken 
as statistically validated data of vessel density in the different tissues.
TABLE II -  MEAN PERCENTAGE OF av|33-POSITIVE VESSELS OUT OF FOUR 
DIFFERENT FIELDS/SECTION. EACH ■  STANDS FOR ONE CARCINOMA, EACH
□  STANDS FOR ONE NORMAL TISSUE
Estimated proportion of stained microvessels 
Tissue --------------------------------------------------------------
0-30% 31-50% 51-70% 71-100%
Colon carcinoma 
n =  15 
Normal colon
n =  5
■  ■ ■
□
■  ■ ■ ■ ■  
■  ■ ■ ■
□  □ □ □
■  ■ ■
Pancreas carcinoma
n — 10
■ ■ ■  ■ ■  
■  ■
■  ■ ■
Normal pancreas 
n =  5
□ □  □ □ □
Lung carcinoma 
n = 13 
Normal lung 
n =  3 
Breast carcinoma 
n =  12
Normal breast 
n =  3
□  □  
□  □ □
□
■  ■ ■  
■  ■ ■
m m m
■ ■ ■
■ ■ ■
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avp 3 stainings, a comparison was made with the stainings of 2 
different antibodies directed to the avp5-complex. Both anti-av|35 
antibodies showed a characteristically different staining pattern 
from that obtained with LM609 (not shown).
In all carcinoma lesions investigated, ctvp3-expressing vessels 
were found. The percentages of LM609~positive vessels as a 
fraction of the entire actual vasculature, defined by PAL-E-staining, 
showed wide variations, and all tumor types had examples of single 
lesions with less than 50% ctvp3-expressing vessels. Some of these 
lesions, showing LM609-staining on endothelial as well as on other 
cells, were difficult to evaluate as the avp3 expression of tumor 
and/or stromal cells partly obscured the vascular staining. There­
fore, the degree of vascular expression may have been underesti­
mated in these sections. However, 35 out of 50 carcinoma lesions 
of different origins showed av(33 expression on more than half of 
their tumor-associated vessels.
Colon
Normal colonic tissue showed avp3 expression on different 
mesenchymal cell types. The tunica muscularis consisted of 
strongly stained smooth-muscle cells, making it impossible to see 
vascular staining. In the lamina mucosa the same feature appeared. 
Staining of connective-tissue cells partially obscured the vascular 
avp3 expression, but single capillaries showing LM609-staining 
could be identified on the basis of PAL-E-staining in serial sections. 
In the lamina submucosa, av(33 expression was found on about 
40-60% of the PAL-B-defined vessels (Fig. 1, a,b). Approximately 
40% of the stained vessels belonged to the arterial system, 
expressing avp3 both on endothelial and on smooth-muscle cells. 
Out of 15 carcinoma lesions, 12 showed avp3 on more than 50% of 
their PAL-E-deftned vessels. Interstitial stromal cells were, with 
variable intensity, stained for av(33 in all lesions, but no positive 
tumor cell was seen.
Pancreas
In normal pancreatic tissue the percentage of avp3~expressing 
vessels ranged from 25% to 60%. The lesions of pancreatic 
carcinomas showed 30% to 80% LM609-positive vessels. In both 
lesions with less than 50% av33-expressing vessels, strongly 
positive stromal and tumor cells were seen in about half of the 
section, partially obscuring the LM609 staining. In 2 carcinoma 
lesions with more than 70% avp3~expressing vessels, normal 
pancreas tissue could be found in the same section. The percentage 
of vessels stained with LM609 in such areas was lower (40% to 
60%) than in the carcinoma and the staining intensity on individual 
vessels was weaker (Fig. 2a-d). Single lesions showed inflamma­
tory infiltrates surrounded by many a v(B3-expressing vessels.
Lung
The percentage of LM609-positive vessels in normal lung 
tissues was less than 35% in all lesions investigated. Only a few 
capillaries within the interalveolar septa were stained by LM609, 
whereas all detectable small and medium-sized venules and 
arterioles expressed avp3. The arterioles especially showed stain­
ing not only of endothelial, but also of smooth-muscle cells in the 
tunica media. Out of 13 lung carcinomas, 9 showed avp3 
expression on more than 50% of their vessels. The 2 lesions with 
the highest percentages of stained vessels (80% and 90%) were 
partly necrotizing, squamous-cell carcinomas. In some lesions 
extensive inflammatory infiltrates could be seen, Within and 
surrounding these infiltrates the percentage of av(33-expressing 
vessels was high and the staining intensity was strong. Stromal 
cells were stained with LM609 in some cases and a few lesions 
showed positively stained tumor cells.
Breast
Only a weak LM609 staining of less than 25% of the PAL-E- 
defined vessels was detectable in normal breast tissues. The 
percentage of avftf-expressing vessels in breast carcinomas ranged 
from 40% to 70%. One lesion showed normal breast and carcinoma
tissue within the same section. The vasculature in the tumorous part 
showed a higher expression of avp3 (both percentage and staining 
intensity). In single carcinoma tissues, inflammatory infiltrates 
surrounded by many avp3-expressing vessels could be seen. Most 
lesions showed LM609 staining of stromal cells, while a few 
showed positive tumor cells. In some carcinomas, avp3 was 
expressed on a cell layer surrounding tumor-cell nests, Schwann 
cells also expressed avp3.
In the evaluation of avp3 expression in normal tissue, we had to 
consider that we used autopsy tissues which post mortem had been 
subjected to hypoxic conditions. Since integrin expression might 
have been altered by post mortem hypoxia, we used rabbit tissue to 
investigate whether the time between death and tissue sampling 
influenced vascular avp3 expression, LM609 recognizes avP3 on 
angiogenic vessels in rabbits (Friedlander et ai, 1995). On the 
vasculature of normal rabbit tissues, little avp3 expression could 
be detected, irrespective of the time which had elapsed between 
death of the animal and tissue sampling.
DISCUSSION
Integrin av(33 is strongly implicated in tumor angiogenesis 
(Brooks et ai, 1994a,b; 1995). We investigated 4 different human 
carcinomas and the corresponding normal tissues to identify which 
expressed avp3 on vessels. By contrast with recent studies with 
antibodies directed to individual integrin chains (Mechtersheimer 
et ai, 1994; Luscinskas and Lawler, 1994), we used LM609 that 
binds only to intact and functionally active avp3-complex (Cheresh 
and Spiro, 1987), and used PAL-E (Schlingemann et a i , 1985) 
rather than anti-factor-VIII-related antigen antibody as an endothe­
lial marker. This allowed us to routinely distinguish staining of 
endothelial cells and smooth-muscle cells of the media. In addition 
to the study of avP3 staining detailed here, we examined the 
distribution of the avp5 integrin to investigate whether the 
observed avP3 distribution was specific. avp5-comp!ex specific 
antibodies gave staining patterns which were characteristically 
different from those of avp3, showing, in particular, a much 
broader tissue distribution and thereby suggesting the specificity of 
the immunohistochemical staining for avp3.
avp3 is expressed on angiogenic vessels in man, chicken and 
rabbit (Brooks et ctl, 1994a; Friedlander et cii, 1995) and 
expression and ligation of avP3 on endothelial cells of sprouting 
vessels seems to protect them from apoptosis (Brooks et cii, 
1994/;). This led to the hypothesis, that avp3 expression is part of 
the specific phenotype of angiogenic vessels (Brooks eta /., 1994b).
Here, we observed extensive cevP3 expression on vessels in 
normal tissues. In most organs avp3 was expressed on less than 
50% of the PAL-E-defined vessels, but 1 out of 5 pancreatic and 4 
out of 5 colonic tissues showed staining of more than 50% of their 
vasculature. In all lesions, small and medium-sized vessels ex­
pressed avp3. LM609 stained not only the endothelia but also the 
smooth-muscle cells in the vessel media. The distribution of av(33 
observed by us in normal tissues is similar to that previously 
reported for isolated av- and p3-subchains (Mechtersheimer etctl, 
1994). The interpretation of those earlier studies, however, was 
hampered by the fact that they did not use complex-specific 
antibodies and both av and p3 potentially combine with multiple 
partner chains. We were able to show that cxvP3 expression on 
normal vasculature is probably not a post mortem artefact since no 
significant differences in LM609 could be found on vessels of any 
of the rabbit organs studied, comparing samples taken from these 
immediately, 1 hr or 8 hr after death. To confirm this on human 
tissue, we are now investigating different colorectal and dermal 
biopsies.
Comparison of the avp3 expression in neoplastic and normal 
tissue of pancreas, lung and breast shows an increase in LM609 
staining in many carcinomas. This supports a link between 
angiogenesis and enhanced avp3 expression (Brooks et ai,
VASCULAR «v(33 EXPRESSION IN HUMAN CARCINOMAS 323
* •*!
: * ¡ M
'•C-
¡ av) . ' A I
• .  ^ •
V. 1
i
r v.- . V , . . '  < l .
U í  W *  ■: : .  v t 1*1-' '
' ' : X  fL Í \ * *  < ?1 
; -  *  : -
■ B 'k 'V  >
#■< > J
*■>
i ^
: 1 7*.
V N
V i  ■ j '
■ ■ c
" ,  i -
s
•  v>: > * ' '
*
Vv
- i i  
t* :
&
v .
,v
.'ói
:i£ .
$
.i« -
• ’ l "  I t
H ¡ M
' ,  I
' o
m
,  , ,  r* I
,  /  ', ' : v
i
; • ,  « , , ,  ' ,< i \
•/ : v ^ i y . / v ; :
• • ’■-.y ; v -  ::
. .  .  .  '  - ^ ' s f * Y ; : .  : •  • W  v
••.•■' . . .  , j/ : .tfv:.;» '■
• .
.  • i ;•
y >
•<.  *» * . V •
•fi
i i
[Á\
i
• s
VA
*
ft
*
r fijt  1
¡Á: '
j K : ?• ,: ' . <V>- ■■■':•>'■;■■ . . .  - .. -I" . - .-?■■ :..
■ ;-V -^  r v ■; y  ■
ü:-- ^  '■ j é  -  ¡ .. . - iA  ' !i ;v  ■ • *  , , ■; ^ ; ■:: M  -5 *1 -
*
■•" • .s' . '"' .♦ *
W :  -V ..<•■■ - K "  ■■:$ . ; •
- =. ^  -‘¿vV;
!á sr--'1- -■: 1 ■ r " -Jíí-
. *  •‘T -  f v . ,  ■••.*•' .  • ;% ' -  V ': ,  -
■' : :■ S i ,
T ? y .  .f> ■ ‘¿ á # ,  t  
i í ' .
■*>/ r
H-'- ^
• ’/tI m m
i
r *
J.:-
..¿ ti» :
' i '  : 
^  .S :
•i¡*
1
■Jl
y;"-
• -fv.'
’■H
' t
/ '  _ M r x ' %
'  . < #8 '^  ?:í4"
'-; . & M  ■ ¿ K  ^
■ • - v ^  f f i / V  
‘ i : : “' 5-.:.V:!l
-  >r^ . '
? N t . .  v
.
í
B í
S
” ,ÍS - r f  j i ^  í $$>■ 
■^■y ■$? ', V -  .
,.-V  1
' .  - '^ í í I Í í M R ^ - '
i
: Í f W ^ ,  ’I f i  -
:.v /  ■ \
‘^ í r
''C'aÍ'.;
.:¡¿¿ :? v.' :^ > .
s 4 ‘
y'v.- .vs:}s¿,y '4 ■"If- < .rmi:H ' "§
'  „
■Jf
1 '-V'. v
, . : . f .  J '
V’
•1
■ V ■ *
1,'. •¡•i'-’'?» .'• 'V jr. i'íl,-; -lWi
. •
S » „  '■•
V»W
* (• m i . . .
•  V n  v//* -
j # '  j/ • >• l', ■ ■'Sí-'*V- ‘  ^ Sií• i: . '
•V4RI-?
' . í-
i .s': 'i \
■. i : ■/..
' - ' W :
i
. " - \ y '  
: . '. :)s:' "
'■ ' 
I
;:^f.
•V?,
*:Vi:
> ■
rV
, *vN.
7 '
I
\ c
 ^í • i!' : '.i*
: >>:
;|k :
V - . W ;  
:1 ■ ‘ ? ■
l }i\\. 'W
■:■'-K-
* i'/ ►'>■:•
VvV:;:-:
ri í T
C[y: •;
v # -
. i ;
'.Vi;
/
' í ',s:
'  . v  ! '  :
' V.’.: 
'j’i
' v'< , 'í •
;íV¿yv
•y,y
r.
f :r**
• ƒ::• ,  \ír
I
r
<#•
• • s%y g', > > • • • i •; r
;•,*; .  !fl/ H
r’-:í»Fí?i'-
■:,m.
. ./i«]:
:;.U-S vi S
V>í
.v/.Vj-
. V . XV:l
\ v ,
\ t y  i-
i .w:*
J - # '.
I \
r ^ . .
fe
U'
. : i \ ' / .
-:-’í
i# :v - . ' ’' 
1 '• ' «é'> i
•^'j ¿ü1
A 4. ’ -
«i :•,
:V k
*
<v.
.r¡?
l :í?  "  %
lOi.il
i  ^ \  • A
■ n  v* ■
U  /
ii :
A
<*
i
M ;:
> /
W -i
í ! !
• t i
i
: h iv
U.r
■:4;- ; 
M 3ÉV
' ■, i. .V
■.J5t
í>.
i,, .
A
■K
7-sr¿
:¿^ r
í.f!
/■I
í , >
:«:í> AV'.:
r,>i:
' / • t i
\ U :
" :> *.s
V¿r
'/ ' . . .  •.•.*.
M  . .
í¿J:-ví: . ' ^ *'Y>.\¿ ■'-.&* :' • "'^
■:íí:
■ ,'^ i;
I  
• i í :'
>v í
^  ‘ :fr:; 
■■
í V:
1
«
:Í':
-íá •-V
«O '
ú ;■«■
v.MijÚ . . * ■.^:.V.'.
»• ■
-.r.
,.-Jvr
/
'iCV'J
■>. ■.
'v" v ■*' ■:■
.t
i :
':.^V■7', •'.. ■
■i:' ¿V
íív- 'Íí
Figure 2 -  Microphotographs of a pancreatic carcinoma lesion sJiowing normal (a, b) and neoplastic (c, d) areas in the same section. Serial 
cryostat sections were stained with the endothelial marker PAL-E (a, c) and LM609 anti-av(33 MAb (b, cl). Bars: 13 ¡am (a ,  b) and 27 \.\m (cf d).
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vessels in normal and neoplastic tissue, there also seems to be a 
stronger staining in tumors. This may be due to a higher oev(33 
expression or a greater exposure of the LM609 epitope. Although 
. staining intensities can be influenced by interassay variation, single 
lesions showing normal and neoplastic areas in the same section 
confirmed the differences in amount and intensity of staining.
In breast carcinomas, av(33 expression revealed by the use of 
LM609 has been described on all the tumor vasculature of the 
lesions (Brooks et a l t 1995). Here, the vascular avp3 expression in 
breast carcinomas ranged from 40% to 70%. This might be due to
. Unlike
the PAL-E antibody, these antibodies often fail to stain tumor 
capillaries (Schlingemann e ta i,  1991) and will, therefore, underes­
timate the actual (micro-) vessel density.
In some carcinomas the vasculature within and surrounding 
inflammatory infiltrates showed more and more intensely stained
vessels compared to the rest of the section. As tumor-induced 
angiogenesis may be initiated by release of angiogenic factors from 
tumor and inflammatory cells (Leek et al, 1994), this appears to 
indicate that angiogenesis might be enhanced by inflammatory 
cells.
Hypoxia may also lead to neovascularization. We saw single 
carcinomas with necrotic, presumably hypoxic, regions, sur­
rounded by many avp3-expressing vessels. This may indicate 
hypoxia-induced upregulation of vascular av(33 expression compa­
rable to what has been reported for VEGF expression in human 
glioblastomas. There, tumor cells in immediate proximity to 
necrotic foci but not in non-necrotic areas produce VEGF, a known 
angiogenic cytokine (Shweiki et al, 1992).
In summary, our data confirm and extend earlier reports on the 
upregulation of av(33 expression on the tumor vasculature. How­
ever, they also show that av|33 expression is not limited to areas of 
neovascularization and that the expression in normal tissue does 
not appear to be due to hypoxia or to a tissue-sampling artefact.
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Unlike previous work (Mechtersheimer et aL, 1994; Luscinskas 
and Lawler, 1994) anti-avp3 antibodies rather than single-chain 
specific anti-av or p3-antibodies were used for our analysis and 
endothelial avp3 expression was more rigorously differentiated 
from avJ33 expression on the media.
There are as yet no clues regarding the function of avp3 
expression in normal tissue. This might indicate angiogenic acti vity 
below the level documented previously by enumeration of mitotic
figures of endothelial cells, although this is unlikely. Alternatively, 
it is possible that cxvp3 expression on the normal vasculature does 
not serve any angiogenic function at all, and endothelial cells in 
normal tissue do not depend on avj33 ligation for survival.
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